Clinical Diagnosis and Prognosis of Hepatobiliary and Pancreatic Diseases
This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Special Issue Information
Dear Colleagues,
Hepatobiliary and pancreatic (HPB) diseases, encompassing benign and malignant conditions of the liver, biliary tract, and pancreas, remain a major source of morbidity and mortality worldwide. Their frequently silent clinical course and the anatomical complexity of the region render timely diagnosis and accurate prognostication particularly challenging, whilst late presentation continues to limit curative treatment options. We are pleased to invite you to contribute to this Special Issue dedicated to advances in the clinical diagnosis and prognosis of HPB diseases.
This Special Issue aims to bring together high-quality research on diagnostic modalities, biomarkers, and prognostic tools that may improve early detection, risk stratification, and clinical decision-making in HPB conditions, in line with the scope of Diagnostics.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: imaging of hepatobiliary and pancreatic diseases; liquid biopsy and circulating biomarkers; endoscopic and interventional diagnostics; surveillance of high-risk individuals and premalignant lesions; prognostic models and nomograms; and artificial intelligence in HPB diagnostics.
We look forward to receiving your contributions.
Dr. Ioannis Katsaros
Dr. Michail Vailas
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepato-pancreato-biliary diseases
- pancreatic cancer
- hepatocellular carcinoma
- cholangiocarcinoma
- diagnosis
- prognosis
- biomarkers
- liquid biopsy
- medical imaging
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

